BDNF and Cognitive impairment: Intrahippocampal infusions of TAT-Pep5 and exogenous administration of BDNF could attenuate surgery-induced cognitive deficits via tuning the ratio of BDNF/proBDNF and alleviate the deficiency of synaptic function, which is supposed to be a potential therapeutic target in future POCD prevention.